Contact this trialFirst, we need to learn more about you.
124I-Evuzamitide for Amyloidosis
Recruiting1 awardPhase 2
Portland, Oregon
This trial looks at how a new drug affects people with systemic amyloidosis, by tracking its distribution and how it affects organs like the heart. Patients will have MRI and CT scans to measure changes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service